A Multicenter, Randomized, Open-label Phase 3 Study of Rucaparib versus Physician'sChoice of Therapy for Patients with Metastatic Castration resistant Prostate Cancer Associated withHomologous Recombination Deficiency

Project: Research project

Project Details

Description

A Multicenter, Randomized, Open-label Phase 3 Study of Rucaparib versus Physician's Choice of Therapy for Patients with Metastatic Castration resistant Prostate Cancer Associated with Homologous Recombination Deficiency
StatusActive
Effective start/end date4/1/184/30/23

Funding

  • CLOVIS ONCOLOGY, INC.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.